← Open Payments lookup

MARIA CALZADA: Open Payments

NPI 1508960824 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,250 in 61 payments from 10 companies in 2025. Trend: 2023 $24 · 2024 $145 · 2025 $1,250

Food & beverage: $1,250
CompanyPaymentsAmount
Cumberland Pharmaceuticals, Inc.25$354
ViiV Healthcare Company10$249
ABBVIE INC.15$184
MIMEDX Group, Inc.1$126
Esperion Therapeutics, Inc.1$102
Paratek Pharmaceuticals, Inc.5$94
Bayer Healthcare Pharmaceuticals Inc.1$59
EMD Serono, Inc.1$31
Aimmune Therapeutics, Inc.1$28
Smith+Nephew, Inc.1$24

Products named: VIBATIV, DOVATO, NEXLETOL, NUZYRA, EMBLAVEO, AVYCAZ, Kerendia, CABENUVA.

Industry payments across TX — which companies pay providers there.